ARCHIVES

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Puts Clinical Hold On Gene Therapy Trials

January 24, 2003

ACCC Presses Drive for “DG 471” But Former President Says it’s Counterproductive

March 30, 1984

Transplant Is Viable Option For HIV+ Patients, Study Finds

February 25, 2005

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

September 9, 1994

Neurocognitive Deficits Affect Future Adult Employment

September 30, 2011

FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say

January 26, 1996